

Photo: Cubadebate
The Cuban Center for State Control of Medicines, Equipment and Medical Devices approved the phase I/II clinical trial to evaluate the safety and immunogenicity of the vaccine candidate Mambisa -intranasal- and the Abdala vaccine -intramuscular-, a study to boost immunity in convalescents of COVID-19.
Read more Cuba approves clinical trial with Mambisa and Abdala in COVID-19 convalescentsPage 398 of 491